凯捷：2026年生命科学工程与研发洞察报告：变局时代行业高管如何统筹研发效率、灵活落地与合规管控（英文版）（35页）.pdf

1、Click here or press enter for the accessibility optimised versionHow are life sciencesengineering leadersbalancing speed,agility,and compliance,in anage of disruption?Life Sciences Engineeringand R&D Pulse Report 2026Report scopeThis report presents the key insights from the LifeSciences Engineering

2、 Pulse 2026,part of ourbroader crosssector Engineering&R&D Pulse.It is based on a global survey of 200 senior lifesciences leaders from large organizations acrosspharmaceuticals,biotechnology,medical devices,and digital health.Respondents are senior decision-makers responsiblefor engineering across

3、the entire product lifecycle from early R&D and design to regulatory and qualitycompliance,industrialization,supply chainoperations,and commercialization.The quotes and case studies included are illustrativein nature,may be drawn from publicly availablesources,and do not necessarily reflect the view

4、s orstatements of survey respondents.The data in the report was gathered by the Capgemini Research Institute in August 2025 viaa survey of executives at organizations with more than$1 billion in annual revenue.Thisdata is from a subset of 200 Life Sciences C-level and Senior Leadership across NorthA

5、merica,Europe,APAC,and the Middle East.Subsector breakdown:PharmaceuticalsMedTechBiotechnologyLab automation and research toolsDigital health and Software-as-a-Medical Device(SaMD)ReportdemographicsWhat youwill learnA practical lens on the forcesdriving change and the solutionsleading organizations

6、areadopting.Few industries share the life sciences weight of responsibility.Every drug approved,every device deployed,every therapy developed has a direct bearing onhuman health and quality of life.Yet the organizations entrusted with that responsibility areoperating in one of the most complex envir